Literature DB >> 11808864

Variability of oral bioavailability for low dose methotrexate in rats.

T Kuroda1, K Namba, T Torimaru, S Yamamoto, M Akahori.   

Abstract

The effects of food, antibiotics, diclofenac sodium (DS) and methotrexate (MTX) on oral bioavailability (BA) of MTX were examined in rats. Feeding didn't vary the plasma concentrations after intravenous dosing of 0.5 mg/kg MTX, but enhanced those after oral dosing, and the oral BA. The twice daily oral doses of 40 mg/kg neomycin sulfate (NS) or mixed antibiotics (200 mg/kg NS + 200 mg/kg streptomycin sulfate + 200 mg/kg bacitracin) for 5 days didn't influence the plasma concentrations after intravenous dosing of 0.5 mg/kg MTX, but induced the decreased Cmax and the delayed MRT after oral dosing. The plasma concentrations after intravenous or oral dosing of 2.5 mg/kg MTX in rats orally dosed with 1 or 5 mg/kg/day DS for 4 days were similar to those in the control rats, while the pre-treatment of 25 mg/kg/day DS delayed the elimination of MTX but didn't change the oral BA. The plasma concentrations after intravenous or oral dosing of 2.5 mg/kg MTX in rats, which received the intermittent oral doses of 7.5 mg/kg/3 doses/week MTX for 4 weeks, were comparable to those in the control rats, but the daily pre-treatment of 0.2 mg/kg/day MTX for 4 weeks increased the plasma concentrations after oral dosing, and the BA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11808864     DOI: 10.1007/BF03226376

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  32 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of methotrexate.

Authors:  D D Shen; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

3.  Effect of route of administration and effusions on methotrexate pharmacokinetics.

Authors:  S H Wan; D H Huffman; D L Azarnoff; R Stephens; B Hoogstraten
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

4.  Effects on intestinal microflora, gastrointestinal tolerability and antiinflammatory efficacy of diclofenac and nitrofenac in adjuvant arthritic rats.

Authors:  L Cuzzolin; A Conforti; M Donini; A Adami; P Del Soldato; G Benoni
Journal:  Pharmacol Res       Date:  1994 Jan-Feb       Impact factor: 7.658

5.  Low-dose methotrexate-induced changes in intestinal permeability determined by polyethylene glycol polymers.

Authors:  C H Lifschitz; D H Mahoney
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-10       Impact factor: 2.839

6.  Regulation of the PepT1 peptide transporter in the rat small intestine in response to 5-fluorouracil-induced injury.

Authors:  H Tanaka; K I Miyamoto; K Morita; H Haga; H Segawa; T Shiraga; A Fujioka; T Kouda; Y Taketani; S Hisano; Y Fukui; K Kitagawa; E Takeda
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

7.  A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months.

Authors:  J M Kremer; J K Lee
Journal:  Arthritis Rheum       Date:  1988-05

8.  The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.

Authors:  J M Kremer; R A Hamilton
Journal:  J Rheumatol       Date:  1995-11       Impact factor: 4.666

9.  Clinical pharmacology of intermediate-dose oral methotrexate.

Authors:  D K Smith; G A Omura; F Ostroy
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

10.  Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.

Authors:  P Statkevich; D J Fournier; K R Sweeney
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

View more
  1 in total

1.  Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis.

Authors:  Ismaiel A Tekko; Andi Dian Permana; Lalitkumar Vora; Taher Hatahet; Helen O McCarthy; Ryan F Donnelly
Journal:  Eur J Pharm Sci       Date:  2020-07-15       Impact factor: 4.384

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.